These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


350 related items for PubMed ID: 12847397

  • 1. Endothelial cells play an important role in the antiaggregatory effect of nitric oxide.
    Klinge JM, Topf HG, Trusen B, Rauh M, Rascher W, Dötsch J.
    Crit Care Med; 2003 Jul; 31(7):2010-4. PubMed ID: 12847397
    [Abstract] [Full Text] [Related]

  • 2. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S, Olszanecki R, Marcinkiewicz E, Lomnicka M, Motterlini R.
    Cardiovasc Res; 2006 Jul 15; 71(2):393-401. PubMed ID: 16713591
    [Abstract] [Full Text] [Related]

  • 3. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
    Jurasz P, Sawicki G, Duszyk M, Sawicka J, Miranda C, Mayers I, Radomski MW.
    Cancer Res; 2001 Jan 01; 61(1):376-82. PubMed ID: 11196190
    [Abstract] [Full Text] [Related]

  • 4. Nitric oxide and platelet energy metabolism.
    Tomasiak M, Stelmach H, Rusak T, Wysocka J.
    Acta Biochim Pol; 2004 Jan 01; 51(3):789-803. PubMed ID: 15448739
    [Abstract] [Full Text] [Related]

  • 5. Platelet activation triggered by Chlamydia pneumoniae is antagonized by 12-lipoxygenase inhibitors but not cyclooxygenase inhibitors.
    Kälvegren H, Andersson J, Grenegård M, Bengtsson T.
    Eur J Pharmacol; 2007 Jul 02; 566(1-3):20-7. PubMed ID: 17459368
    [Abstract] [Full Text] [Related]

  • 6. Inhibition by nitric oxide-releasing compounds of prostacyclin production in human endothelial cells.
    Kosonen O, Kankaanranta H, Malo-Ranta U, Ristimäki A, Moilanen E.
    Br J Pharmacol; 1998 Sep 02; 125(2):247-54. PubMed ID: 9786495
    [Abstract] [Full Text] [Related]

  • 7. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men.
    Adams MR, Forsyth CJ, Jessup W, Robinson J, Celermajer DS.
    J Am Coll Cardiol; 1995 Oct 02; 26(4):1054-61. PubMed ID: 7560599
    [Abstract] [Full Text] [Related]

  • 8. Oxidized LDL and reduction of the antiaggregating activity of nitric oxide derived from endothelial cells.
    Minuz P, Lechi C, Gaino S, Bonapace S, Fontana L, Garbin U, Paluani F, Cominacini L, Zatti M, Lechi A.
    Thromb Haemost; 1995 Oct 02; 74(4):1175-9. PubMed ID: 8560431
    [Abstract] [Full Text] [Related]

  • 9. Nitric oxide induces angiogenesis and upregulates alpha(v)beta(3) integrin expression on endothelial cells.
    Lee PC, Kibbe MR, Schuchert MJ, Stolz DB, Watkins SC, Griffith BP, Billiar TR, Shears LL.
    Microvasc Res; 2000 Nov 02; 60(3):269-80. PubMed ID: 11078643
    [Abstract] [Full Text] [Related]

  • 10. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.
    Salvemini D, Currie MG, Mollace V.
    J Clin Invest; 1996 Jun 01; 97(11):2562-8. PubMed ID: 8647949
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors.
    Kobzar G, Mardla V, Samel N.
    Platelets; 2011 Jun 01; 22(5):338-44. PubMed ID: 21557683
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin.
    Chakraborty K, Khan GA, Banerjee P, Ray U, Sinha AK.
    Platelets; 2003 Jun 01; 14(7-8):421-7. PubMed ID: 14713511
    [Abstract] [Full Text] [Related]

  • 14. Simvastatin elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and mevalonate-rho kinase pathways.
    Nagaoka T, Hein TW, Yoshida A, Kuo L.
    Invest Ophthalmol Vis Sci; 2007 Feb 01; 48(2):825-32. PubMed ID: 17251484
    [Abstract] [Full Text] [Related]

  • 15. Nitric oxide mediates interactions between GABAA receptors and adenosine A1 receptors in the rat hippocampus.
    Fragata IR, Ribeiro JA, Sebastião AM.
    Eur J Pharmacol; 2006 Aug 14; 543(1-3):32-9. PubMed ID: 16831416
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
    Sogo N, Magid KS, Shaw CA, Webb DJ, Megson IL.
    Biochem Biophys Res Commun; 2000 Dec 20; 279(2):412-9. PubMed ID: 11118301
    [Abstract] [Full Text] [Related]

  • 17. The long-term exposure of endothelial cells to molsidomine increases their antithrombogenicity by inducing the production of nitric oxide-related chemical substances.
    Berenger-Bahuet FP, Rolland PH.
    J Cardiovasc Pharmacol; 1989 Dec 20; 14 Suppl 11():S98-105. PubMed ID: 2484710
    [Abstract] [Full Text] [Related]

  • 18. Regulatory role of nitric oxide over extracellular taurine in the hippocampus of freely moving rats.
    Watts J, Segieth J, Pearce B, Whitton PS.
    Neurosci Lett; 2004 Mar 11; 357(3):179-82. PubMed ID: 15003279
    [Abstract] [Full Text] [Related]

  • 19. The calcium modulator nifedipine exerts its antiaggregatory property via a nitric oxide mediated process.
    Berkels R, Klaus W, Boller M, Rösen R.
    Thromb Haemost; 1994 Aug 11; 72(2):309-12. PubMed ID: 7831670
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.